Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
14.21
-0.13 (-0.87%)
Apr 1, 2025, 10:41 AM EDT - Market open

Avanos Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
687.8673.3684.1587714.8
Upgrade
Revenue Growth (YoY)
2.15%-1.58%16.54%-17.88%2.47%
Upgrade
Cost of Revenue
306.5293.6289.9287.8343.9
Upgrade
Gross Profit
381.3379.7394.2299.2370.9
Upgrade
Selling, General & Admin
321.1321.4326.5257.2327.2
Upgrade
Research & Development
12.412.629.230.634.9
Upgrade
Other Operating Expenses
33.337.34.4
Upgrade
Operating Expenses
336.5337.3358.7295.1366.5
Upgrade
Operating Income
44.842.435.54.14.4
Upgrade
Interest Expense
-12.2-15-10-3.3-15.6
Upgrade
Interest & Investment Income
5.12.91.20.21.2
Upgrade
EBT Excluding Unusual Items
37.730.326.71-10
Upgrade
Merger & Restructuring Charges
-8.1-28.2--28.1-25.4
Upgrade
Impairment of Goodwill
-336.5----
Upgrade
Asset Writedown
-100.2----
Upgrade
Legal Settlements
--10--15-27.5
Upgrade
Other Unusual Items
3.8----
Upgrade
Pretax Income
-403.3-7.926.7-42.1-62.9
Upgrade
Income Tax Expense
-1725.2-11.2-33.9
Upgrade
Earnings From Continuing Operations
-386.3-9.921.5-30.9-29
Upgrade
Earnings From Discontinued Operations
-5.8-51.92937.2-
Upgrade
Net Income
-392.1-61.850.56.3-29
Upgrade
Net Income to Common
-392.1-61.850.56.3-29
Upgrade
Net Income Growth
--701.59%--
Upgrade
Shares Outstanding (Basic)
4647474848
Upgrade
Shares Outstanding (Diluted)
4647474948
Upgrade
Shares Change (YoY)
-1.29%-1.48%-2.67%1.67%0.42%
Upgrade
EPS (Basic)
-8.52-1.331.080.13-0.61
Upgrade
EPS (Diluted)
-8.53-1.331.080.13-0.61
Upgrade
EPS Growth
--722.10%--
Upgrade
Free Cash Flow
82.914.671.666.3-22.7
Upgrade
Free Cash Flow Per Share
1.800.311.511.36-0.47
Upgrade
Gross Margin
55.44%56.39%57.62%50.97%51.89%
Upgrade
Operating Margin
6.51%6.30%5.19%0.70%0.62%
Upgrade
Profit Margin
-57.01%-9.18%7.38%1.07%-4.06%
Upgrade
Free Cash Flow Margin
12.05%2.17%10.47%11.29%-3.18%
Upgrade
EBITDA
90.385.976.742.447.3
Upgrade
EBITDA Margin
13.13%12.76%11.21%7.22%6.62%
Upgrade
D&A For EBITDA
45.543.541.238.342.9
Upgrade
EBIT
44.842.435.54.14.4
Upgrade
EBIT Margin
6.51%6.30%5.19%0.70%0.62%
Upgrade
Effective Tax Rate
--19.48%--
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q